TCL Archive Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say July 24, 2009
TCL Archive With Flashing Lights, Heckling, and Folk Song, Avastin Sets New Tone for FDA Debates July 1, 2011
TCL Archive “Comprehensive” Tag For Centers A Poor Choice, Word-Conscious NCI Staff, Committee Feel February 22, 1974
TCL Archive In Brief: Holleb To Retire In June As ACS Vice President; Consensus Conference On Neurofibromatosis Set January 23, 1987
TCL Archive NCI Programs: BSA Approves $30M 5-Year Set-Aside For Leadership Initiative On Cancer November 20, 1998
TCL Archive Bush Nominates von Eschenbach For FDA; Democrats Put Hold On Confirmation. von Eschenbach To Step Down As NCI Director, But Details Unavailable; No Acting Director Named. Applause, Outrage, Over Nomination. Now, von Eschenbach Leads A Retreat From 2015 Target Date For His Challenge Goal. March 17, 2006
